Chargement...

Robocath sets up medical advisory board composed of International interventional cardiology Key Leaders

30 January 2018

Rouen, January 30, 2018 – Robocath, a company that conceives and develops cardiovascular robotic systems for the treatment of vascular diseases, announces today the creation of its medical advisory board including global experts and recognized leaders in interventional cardiology.

This committee will help define the clinical strategy of the company and more broadly contribute to the development of future generations of Robocath’s robotic system products.


Philippe Bencteux, president and founder of Robocath, said: “I’m particularly proud and pleased…

Learn more

Robocath raises a total of €6.4 million ($7.6M) in 2017

6 December 2017

Robocath receives an additional €1.25 million financial contribution from Crédit Agricole Innovations et Territoires (CAIT), an innovation fund managed by Supernova Invest. In line with the company’s growth strategy, the new funding aims to increase the resources available to market the R-OneTM product and launch the development of the next generation of robotics dedicated to the treatment of strokes.

Rouen, December 6, 2017 – Robocath, a company that designs and develops innovative robotic solutions for the treatment of vascular diseases (heart attacks,…

Learn more
4 December 2019

GRCI - France

#Robocath
Subscribe to our newsletter